Monitoring therapeutic response in skeletal metastases using dual-energy x-ray absorptiometry: A prospective feasibility study in breast cancer patients

Cancer Investigation

Volumn 17, Issue 8, 1999, Pages 566-574

  Shapiro, Charles L ^a,c,e   Keating, Jennifer ^a   Angell, Jennifer E ^b   Janicek, Milos ^e   Gelman, Rebecca ^a   Hayes, Daniel ^a,d   LeBoff, Meryl S ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

^e B 421 Starling Loving Hall ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITY; BONE METASTASIS; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; PATIENT MONITORING; PRIORITY JOURNAL; RELIABILITY; TREATMENT OUTCOME;

EID: 0032742198     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909909032841     Document Type: Article

References (28)

1. Hayes DF, Kaplan W: Evaluation of patients after primary therapy. In Diseases of the Breast, edited by JR Harris, ME Lippman, M Morrow, S Hellman, Philadelphia, J B Lippincott Co, 1996, pp. 629-647.
2. Coleman RE, Rubens RD: The clinical course of bone metastases from breast cancer. Br J Cancer 55:61-66, 1987.
3. Clark GM, Sledge GW Jr, Osborne CK, et al: Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol 5:55-61, 1987.
4. Goldhirsch A, Gelber RD, Castiglione M: Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses. J Clin Oncol 6:89-97, 1988.
5. Coleman RE, Rubens RD: Bone metastases and breast cancer. Cancer Treat Rep 12:251-270, 1985.
6. Hayward JL, Rubens RD, Carbone PP, et al: Assessment of response to therapy in advanced breast cancer. Br J Cancer 35:292-298, 1977.
7. Johnson CC, Smelled CAW, Melon LJ: Clinical use of bone densitometry. N Eng J Med 324:1105-1109, 1992.
8. Mazess R, Collick B, Trempe J et al: Performance evaluation of a dual-energy x-ray bone densitometer. Calcif Tissue Int 44:228-232, 1989.
9. Kelly TI, Slovik DM, Schoenfeld DA, et al: Quantitative digital radiography versus dual photon absorptiometry of the lumbar spine. J Clin Endocrinol Metab 67:839-844, 1988.
10. Glüer CC, Steiger P, Selvidge, R, et al: Comparative assessment of dual-photon absorptiometry and dual-energy radiography. Radiology 174:223-228, 1990.
11. Wahner HW, Dunn WL, Brown ML, et al: Comparison of dual-energy x-ray absorptiometry and dual photon absorptiometry for bone mineral absorptiometry for bone mineral measurements of the lumbar spine. Mayo Clin Proc 63:1075-1084, 1988.
12. Slosman DO, Casez JP, Pichard C, et al: Assessment of wholebody composition with dual-energy x-ray absorptiometry. Radiology 185:593-598, 1992.
13. El-Hajj Fuleihan G, Testa M, Angell JE, et al: Reproducibility of DXA absorptiometry: a model for bone loss estimates. J Bone Miner Res 10:1004-1014, 1995.
14. Roberston DD, Mintzer CM, Weissman BN, et al: Distal loss of bone following total knee athroplasty. J Bone Joint Surg 76A:68-76, 1994.
15. Muindi J, Coombes RC, Golding S, et al: The role of computed tomography in the detection of bone metastases in breast cancer patients. Br J Radiol 56:233-236, 1983.
16. Bellamy EA, Nicholas D, Ward M, et al: Comparison of computed tomography and conventional radiology in the assessment of treatment response of lytic bony metastases in patients with carcinoma of the breast. Clin Radiol 38:351-355, 1987.
17. Crone-Munzebrock W, Carl UM: Dual-energy CT-scan quantification of recalcification in ostolyses of the vertebral body due to mammary carcinoma in the course of antineoplastic treatment. Clin Exp Metab 8:173-179, 1990.
18. Janicek MJ, Hayes DF, Kaplan WD: Healing flare in skeletal metastases from breast cancer. Radiology 192:201-204, 1994.
19. Vogel CL, Schoenfelder J, Shemano I, et al: Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancer. J Clin Oncol 13:1123-1129, 1995.
20. Mariette X, Khalifa P, Ravaud P, et al: Bone densitometry in patients with multiple myeloma. Am J Med 93:595-598, 1992.
21. Kamby C, Vejborg I, Daugaard S, et al: Clinical and radiologic characteristics of bone metastases in breast cancer. Cancer 60: 2524-2531, 1987.
22. Twining P, Williams MR, Morris AH, et al: The use of the pelvic radiograph to assess therapeutic response in bone metastases from breast cancer. Clin Radiol 39:583-585, 1988.
23. Libshitz HI: Hortobagyi GN: Radiographic evaluation of therapeutic response in bony metastases of breast cancer. Skeletal Radiol 7:159-165, 1981.
24. Coombes RC, Dady P, Parsons C, et al: Assessment of response of bone metastases to systemic treatment in patients with breast cancer. Cancer 52:610-614, 1983.
25. Scheid V, Buzdar AU, Smith TL, et al: Clinical course of breast cancer patients with osseous metastasis treated with combination chemotherapy. Cancer 58:2589-2593, 1986.
26. Richelson LS, Wahner HW, Melton LJ III, et al: Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med 311:1273-1275, 1984.
27. Riggs BL, Melton LJ III: Involutional osteoporosis. N Engl J Med 326:1676-1686, 1986.
28. Powles TJ, Hickish T, Kanis JA, et al: The effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol. 14:78-84, 1996.